ArticleJournal of ophthalmic inflammation and infection2024

Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

Irmak Karaca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.